mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.09 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.09 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.09 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.09 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.055 |
0.09 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.09 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.09 |
mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
0.27 |
0.09 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.09 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.09 |